Zafgen, Inc. announced the appointment of Priya Singhal, M.D., M.P.H., as Head of Research and Development. Dr. Singhal brings more than a decade of experience as a senior drug development executive and several years of experience as a clinician to her role at Zafgen, where she will lead and oversee the Company’s research, clinical and manufacturing strategy and implementation. She will also serve as a key member of the executive team supporting overall business strategy. Dr. Singhal joins Zafgen most recently from Biogen, where she was concurrently the Senior Vice President and the Global Head of Safety and Benefit Risk Management (SABR) and the Interim Global Co-lead and Senior Vice President of Global Development.